Correlation Between Teva Pharma and Sangui Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Sangui Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Sangui Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharma Industries and Sangui Biotech International, you can compare the effects of market volatilities on Teva Pharma and Sangui Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Sangui Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Sangui Biotech.

Diversification Opportunities for Teva Pharma and Sangui Biotech

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Teva and Sangui is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Sangui Biotech International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangui Biotech Inter and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Sangui Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangui Biotech Inter has no effect on the direction of Teva Pharma i.e., Teva Pharma and Sangui Biotech go up and down completely randomly.

Pair Corralation between Teva Pharma and Sangui Biotech

Given the investment horizon of 90 days Teva Pharma Industries is expected to generate 0.4 times more return on investment than Sangui Biotech. However, Teva Pharma Industries is 2.49 times less risky than Sangui Biotech. It trades about 0.0 of its potential returns per unit of risk. Sangui Biotech International is currently generating about -0.13 per unit of risk. If you would invest  1,864  in Teva Pharma Industries on November 2, 2024 and sell it today you would lose (80.00) from holding Teva Pharma Industries or give up 4.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Teva Pharma Industries  vs.  Sangui Biotech International

 Performance 
       Timeline  
Teva Pharma Industries 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Teva Pharma Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Teva Pharma is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Sangui Biotech Inter 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sangui Biotech International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Teva Pharma and Sangui Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Teva Pharma and Sangui Biotech

The main advantage of trading using opposite Teva Pharma and Sangui Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Sangui Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangui Biotech will offset losses from the drop in Sangui Biotech's long position.
The idea behind Teva Pharma Industries and Sangui Biotech International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes